This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Jun;29(3):484.

doi: 10.1007/s00540-015-2013-0.

Retraction Note to: Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury

Satoshi Hagiwara¹, Hideo Iwasaka¹, Takayuki Noguchi¹

Affiliations

PMID: 25940319
DOI: 10.1007/s00540-015-2013-0

Retraction Note to: Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury

Satoshi Hagiwara et al. J Anesth. 2015 Jun.

. 2015 Jun;29(3):484.

doi: 10.1007/s00540-015-2013-0.

Authors

Satoshi Hagiwara¹, Hideo Iwasaka¹, Takayuki Noguchi¹

Affiliation

¹ Department of Brain and Nerve Science, Anesthesiology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan.

PMID: 25940319
DOI: 10.1007/s00540-015-2013-0

No abstract available

PubMed Disclaimer

Retraction of

Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury.
Hagiwara S, Iwasaka H, Noguchi T. Hagiwara S, et al. J Anesth. 2007;21(2):164-70. doi: 10.1007/s00540-006-0468-8. Epub 2007 May 30. J Anesth. 2007. Retraction in: J Anesth. 2015 Jun;29(3):484. doi: 10.1007/s00540-015-2013-0. PMID: 17458645 Retracted.

Similar articles

Nafamostat mesilate inhibits high-mobility group box 1 by lipopolysaccharide stimulation in murine macrophage RAW 264.7.
Hagiwara S, Iwasaka H, Matumoto S, Noguchi T. Hagiwara S, et al. Shock. 2007 Apr;27(4):429-35. doi: 10.1097/01.shk.0000239778.25775.ad. Shock. 2007. PMID: 17414427
Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury.
Hidaka S, Iwasaka H, Hagiwara S, Noguchi T. Hidaka S, et al. J Surg Res. 2011 Jan;165(1):142-50. doi: 10.1016/j.jss.2009.05.039. Epub 2009 Jun 25. J Surg Res. 2011. PMID: 19766246
Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis.
Lee JK, Ryu JK, Park JK, Lee SH, Yoon WJ, Kim YT, Jung HC, Yoon YB. Lee JK, et al. Pancreas. 2008 Apr;36(3):255-60. doi: 10.1097/MPA.0b013e31815b6b10. Pancreas. 2008. PMID: 18362838
Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients?
Park KT, Kang DH, Choi CW, Cho M, Park SB, Kim HW, Kim DU, Chung CW, Yoon KT. Park KT, et al. Pancreas. 2011 Nov;40(8):1215-9. doi: 10.1097/MPA.0b013e31822116d5. Pancreas. 2011. PMID: 21775918 Clinical Trial.
Aprotinin and nafamostat mesilate in liver surgery: effect on blood loss.
Pereboom IT, de Boer MT, Porte RJ, Molenaar IQ. Pereboom IT, et al. Dig Surg. 2007;24(4):282-7. doi: 10.1159/000103659. Epub 2007 Jul 27. Dig Surg. 2007. PMID: 17657153 Review.

See all similar articles

Cited by

Sterile Neuroinflammation and Strategies for Therapeutic Intervention.
Banjara M, Ghosh C. Banjara M, et al. Int J Inflam. 2017;2017:8385961. doi: 10.1155/2017/8385961. Epub 2017 Jan 3. Int J Inflam. 2017. PMID: 28127491 Free PMC article. Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer